FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1332111000001105: Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24231501000001112 Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54083801000001119 Tenormin 25mg tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Is a Atenolol 25mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Is pack of Tenormin 25 tablets (AstraZeneca) false Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has active ingredient Atenolol false Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has AMP Tenormin 25 tablets (AstraZeneca) true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has specific active ingredient Atenolol true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tenormin 25 tablets (AstraZeneca) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start